Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Sjoukje F Oosting
,
Astrid A M van der Veldt
,
Rudolf S N Fehrmann
,
Corine H GeurtsvanKessel
,
Rob S van Binnendijk
,
Anne-Marie C Dingemans
,
Egbert F Smit
,
T Jeroen N Hiltermann
,
Gerco den Hartog
,
Mathilda Jalving
,
Tatjana T Westphal
,
Arkajyoti Bhattacharya
,
Faye de Wilt
,
Annemarie Boerma
,
Lisanne van Zijl
,
Guus F Rimmelzwaan
,
Pia Kvistborg
,
Cecile A C M van Els
,
Nynke Y Rots
,
Debbie van Baarle
,
John B A G Haanen
,
Elisabeth G E de Vries
More about this publication
The Lancet. Oncology
Volume
23
Issue nr.
7
Pages
833-835
Publication date
01-07-2022
Full text links
Publisher website (DOI)
10.1016/S1470-2045(22)00203-0
Europe PubMed Central
35483383
Pubmed
35483383